Immediate Impact
53 standout
Citing Papers
Current insights and future perspectives of ultraviolet radiation (UV) exposure: Friends and foes to the skin and beyond the skin
2024 Standout
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
2023 Standout
Works of V. Buffard being referenced
Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| V. Buffard | 19 | 29 | 198 | 287 | 187 | 11 | 450 | |
| Kurtis B. Reed | 3 | 6 | 203 | 125 | 164 | 9 | 479 | |
| Michael Krathen | 7 | 36 | 92 | 137 | 242 | 16 | 457 | |
| Anna Peroni | 26 | 6 | 73 | 131 | 242 | 14 | 474 | |
| Carol R. Drucker | 37 | 8 | 246 | 59 | 131 | 13 | 465 | |
| Antonio Rocamora | 11 | 11 | 212 | 78 | 195 | 11 | 381 | |
| M. Vogelbruch | 4 | 35 | 100 | 56 | 162 | 10 | 376 | |
| Wu‐Ching Uen | 2 | 66 | 172 | 223 | 49 | 9 | 493 | |
| John D. Hendrix | 19 | 6 | 71 | 200 | 172 | 17 | 408 | |
| Steven Horwitz | 2 | 32 | 137 | 173 | 353 | 7 | 472 | |
| Marshall E. Kadin | 3 | 28 | 138 | 153 | 334 | 8 | 480 |
All Works
Loading papers...